Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus

MLA

Sue J. Goldie, et al. “Cost Effectiveness of Human Papillomavirus Testing to Augment Cervical Cancer Screening in Women Infected with the Human Immunodeficiency Virus.” The American Journal of Medicine, vol. 111, Aug. 2001, pp. 140–49. EBSCOhost, https://doi.org/10.1016/s0002-9343(01)00780-x.

APA

Sue J. Goldie, Milton C. Weinstein, Thomas C. Wright, Kenneth A. Freedberg, & Karen M. Kuntz. (2001). Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. The American Journal of Medicine, 111, 140–149. https://doi.org/10.1016/s0002-9343(01)00780-x

Chicago

Sue J. Goldie, Milton C. Weinstein, Thomas C. Wright, Kenneth A. Freedberg, and Karen M. Kuntz. 2001. “Cost Effectiveness of Human Papillomavirus Testing to Augment Cervical Cancer Screening in Women Infected with the Human Immunodeficiency Virus.” The American Journal of Medicine 111 (August): 140–49. doi:10.1016/s0002-9343(01)00780-x.